Communiqués

15/05 Forian Inc. Announces Completion of Tender Offer and Closing of Merger AQ
06/04 FORA Stock Alert: Halper Sadeh LLC is Investigating Whether Forian Inc. is Obtaining a Fair Price for its Shareholders BU
03/04 Forian Inc. Enters Into Definitive Agreement to Become a Private Company AQ
14/11 Forian Inc. Announces Third Quarter 2025 Financial Results AQ
30/10/25 Forian Inc. to Announce Third Quarter 2025 Results on November 14, 2025 AQ
25/09/25 Forian : Initial Statement of Beneficial Ownership (Form 3) PU
25/08/25 Forian Receives Unsolicited Proposal from CEO to be Taken Private AQ
13/08/25 Forian : Announces Second Quarter 2025 Financial Results PU
31/07/25 Forian Inc. to Announce Second Quarter 2025 Results on August 13, 2025 AQ
14/05/25 Forian Inc. Announces First Quarter 2025 Financial Results AQ
07/05/25 Forian Inc. to Announce First Quarter 2025 Results on May 14, 2025 AQ
31/03/25 Forian : Announces Restatement of Previously Issued Financials and Affirms 2024 Outlook PU
26/03/25 Forian : to Announce Fourth Quarter and Full Year 2024 Results on March 31, 2025 PU
14/03/25 Forian Inc. to Announce Fourth Quarter and Full Year 2024 Results on March 27, 2025 AQ
16/12/24 Forian Partners With Databricks to Expand Access to Advanced Healthcare Analytics AQ
14/11/24 Forian : Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q) PU
13/11/24 Forian : Announces Third Quarter 2024 Financial Results Form 8 K PU
13/11/24 Forian Inc. Announces Third Quarter 2024 Financial Results AQ
08/11/24 Forian Inc. to Participate in the 13th Annual ROTH MKM Technology Event AQ
06/11/24 Forian : Acquires Kyber Data Science to Enhance Data Analytics Capabilities Form 8 K PU
05/11/24 Forian Inc. to Announce Third Quarter 2024 Results on November 13, 2024 AQ
01/11/24 Forian Acquires Kyber Data Science to Enhance Data Analytics Capabilities AQ
14/08/24 Forian Inc. Announces Second Quarter 2024 Financial Results AQ
02/08/24 Forian Inc. to Announce Second Quarter 2024 Results on August 14, 2024 AQ
25/06/24 Translational Drug Development - Atropos Evidence Network Grows to Over 300 Million Patients Becoming Industry's Largest Federated Healthcare Data Network and Announces Additional Customer AQ
Aucun résultat pour cette recherche